DNA X, Inc.
DNA X, Inc. (SONM) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
sonm · stock forecast · 4 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $5.17
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $5.42 | ↑ 4.78% |
1-day model range: $5.34–$5.5. Peak: $5.5 (+4.78%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SONM · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2020-05-14 | B. Riley FBR | Maintains | Buy→Buy |
| 2019-10-31 | Oppenheimer | Downgrade ↓ | Outperform→Perform |
| 2019-09-11 | B. Riley | Maintains | Buy→Buy |
| 2019-07-18 | B. Riley FBR | Maintains | Buy→Buy |
| 2019-07-09 | National Securities | Upgrade ↑ | Neutral→Buy |
| 2019-06-10 | National Securities | Maintains | Neutral→Neutral |
| 2019-06-04 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on DNA X, Inc. (SONM) stock. Of the recent 7 rating actions, 1 were upgrades and 1 were downgrades. 4 analysts currently cover SONM.
Analyst Recommendation Trends
SONM analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$76M
↑ 21.5% YoY
Revenue Next Year
$108M
↑ 41.0% YoY
EPS This Year
$-333.00
EPS Next Year
$7.20
↓ 102.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast SONM EPS of $-333.00 for the current fiscal year, based on estimates from 1 analysts. The SONM revenue forecast is $76M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The SONM stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SONM price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The SONM short-term stock prediction for tomorrow is $5.42 (+4.78%).
DNA X, Inc. trades on NASDAQ under the ticker SONM. The SONM stock outlook for 2027 is broadly positive, supported by a Buy consensus among 75% of covering analysts.
Frequently asked questions
SONM forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month SONM price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $5.17.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.